Teenagers Risk Severe Side Effects to Use Cancer Drug for Height
Teenagers are increasingly using erdafitinib, a cancer drug, to attempt to increase their height, a practice known as 'heightmaxxing.' Despite severe side effects and lack of medical approval, some teens report significant growth. Experts warn that the drug targets receptors in every cell, with unknown long-term effects, and that growth plates close after puberty, making such interventions dangerous and likely ineffective for most.
